|
Nanobac Pharmaceuticals, Inc. - Company Profile Snapshot
| Company Profile: |
Nanobac Pharmaceuticals, Inc. |
| Ticker: |
NNBP |
| Exchanges: |
OTC |
| 2007 Sales: |
17,621 |
| Major Industry: |
Miscellaneous |
| Sub Industry: |
Medical Services |
| Country: |
UNITED STATES |
| Employees: |
1 |
Business Description
Nanobac Pharmaceuticals, Inc.. The Group's principal activity is the research and development of therapeutic and diagnostic technologies relating to the pleomorphic pathogen known as nanobacterium sanguineum. The Group is biolifescience company which develops diagnostic tests for the detection of Nanobacterial infection, as well as medications that treat atherosclerosis and coronary heart disease. It has a commercially available serology test for the identification of nanobacterial antibodies and antigens. It also conducts biomedical research and clinical studies in the development of atherosclerosis, gall stones, chronic prostatitis, diabetes, arthritic spurs, cataracts, scleroderma, kidney cysts and kidney stones, certain breast pathology, polycystic kidney disease, solid tumor pathologies, immunosuppressed conditions, dental pulp stone, and neurodegenerative disease. It majorly operates in the United States and Finland.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
